tiprankstipranks
Advertisement
Advertisement
Cormedix Earnings Call Highlights Surging Growth, New Risks
PremiumCompany AnnouncementsCormedix Earnings Call Highlights Surging Growth, New Risks
2M ago
Cormedix Earnings Call Highlights Growth, Raises Outlook
Premium
Company Announcements
Cormedix Earnings Call Highlights Growth, Raises Outlook
2M ago
Analyst Reiterates Buy on Cormedix, Maintains Unchanged $13 Price Target Amid Strengthening Commercial Execution and Pipeline Prospects
Premium
Ratings
Analyst Reiterates Buy on Cormedix, Maintains Unchanged $13 Price Target Amid Strengthening Commercial Execution and Pipeline Prospects
2M ago
3 Best Cheap Stocks Under $10 Worth Watching in May 2026
PremiumMarket News3 Best Cheap Stocks Under $10 Worth Watching in May 2026
3M ago
Citizens healthcare analysts hold an analyst/industry conference call
Premium
The Fly
Citizens healthcare analysts hold an analyst/industry conference call
3M ago
CorMedix price target raised to $14 from $13 at RBC Capital
Premium
The Fly
CorMedix price target raised to $14 from $13 at RBC Capital
3M ago
Cormedix: Undervalued Biotech with Differentiated Lead Asset and Attractive Risk‑Reward Justifying a Buy Rating
PremiumRatingsCormedix: Undervalued Biotech with Differentiated Lead Asset and Attractive Risk‑Reward Justifying a Buy Rating
3M ago
Cormedix Earnings Call: Peak DEFENCATH, Tough Road Ahead
Premium
Company Announcements
Cormedix Earnings Call: Peak DEFENCATH, Tough Road Ahead
5M ago
CorMedix Reaffirms DefenCath 2027 Sales and Outlook
Premium
Company Announcements
CorMedix Reaffirms DefenCath 2027 Sales and Outlook
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100